Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KRP297 is a PPAR agonist potentially for the treatment of type 2 diabetes and dyslipidemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 183.00 | |
5 mg | 35 days | $ 720.00 | |
10 mg | 35 days | $ 1,170.00 |
Description | KRP297 is a PPAR agonist potentially for the treatment of type 2 diabetes and dyslipidemia. |
Synonyms | KRP297, MK-0767, L410198, L 410198 |
Molecular Weight | 438.42 |
Formula | C20H17F3N2O4S |
CAS No. | 213252-19-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KRP-297 213252-19-8 KRP297 L-410198 MK-0767 L410198 MK0767 L 410198 MK 0767 KRP 297 inhibitor inhibit